Influence of Vitamin D Deficiency on Cyclin D1-Induced Parathyroid Tumorigenesis
Endocrinology · 2023
DOI: 10.1210/endocr/bqad137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2023. Verfasst von Jessica Costa-Guda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Regenerative Medicine and Skeletal Development, University of Connecticut School of Dental Medicine, Farmington, CT 06030-3101, USA. Hauptthemen laut MEDLINE: Parathyroid Neoplasms, Vitamin D Deficiency. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH, NIDDK.
Abstract (Originalsprache)
Primary hyperparathyroidism (PHPT) is a common endocrinopathy for which several pathogenic mechanisms, including cyclin D1 overexpression, have been identified. Vitamin D nutritional status may influence parathyroid tumorigenesis, but evidence remains circumstantial. To assess the potential influence of vitamin D insufficiency/deficiency on initiation or progression of parathyroid tumorigenesis, we superimposed vitamin D insufficiency or deficiency on parathyroid tumor–prone parathyroid hormone–cyclin D1 transgenic mice. Mice were placed on diets containing either 2.75 IU/g, 0.25 IU/g, or 0.05 IU/g cholecalciferol, either prior to expected onset of PHPT or after onset of biochemical PHPT. When introduced early, superimposed vitamin D insufficiency/deficiency had no effect on serum calcium or on parathyroid gland growth. However, when introduced after the onset of biochemical PHPT, vitamin D deficiency led to larger parathyroid glands without differences in serum biochemical parameters. Our results suggest that low vitamin D status enhances proliferation of parathyroid cells whose growth is already being tumorigenically driven, in contrast to its apparent lack of direct proliferation-initiating action on normally growing parathyroid cells in this model. These results are consistent with the hypothesis that suboptimal vitamin D status may not increase incidence of de novo parathyroid tumorigenesis but may accelerate growth of a preexisting parathyroid tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Regenerative Medicine and Skeletal Development, University of Connecticut School of Dental Medicine, Farmington, CT 06030-3101, USA.
- Center for Molecular Oncology, University of Connecticut School of Medicine, Farmington, CT 06030-3101, USA.
- Section of Oral and Maxillofacial Radiology, UCLA School of Dentistry, Los Angeles, CA 90095, USA.
ORCID-Profile: Jessica Costa-Guda, Andrew Arnold
Förderung
- NIDDK NIH HHS
- NIH
- NIDDK
Zitieren
APA
Costa-Guda, J., Corrado, K., Bellizzi, J., Saria, E., Saucier, K., Guemes-Aragon, M., Kakar, G., Rose, M., Pascal, M., Alander, C., Mallya, S. M., & Arnold, A. (2023). Influence of Vitamin D Deficiency on Cyclin D1-Induced Parathyroid Tumorigenesis. Endocrinology. https://doi.org/10.1210/endocr/bqad137
Vancouver
Costa-Guda J, Corrado K, Bellizzi J, Saria E, Saucier K, Guemes-Aragon M, et al. Influence of Vitamin D Deficiency on Cyclin D1-Induced Parathyroid Tumorigenesis. Endocrinology. 2023. doi:10.1210/endocr/bqad137
BibTeX
@article{CostaGuda2023,
author = {Costa-Guda, Jessica and Corrado, Kristin and Bellizzi, Justin and Saria, Elizabeth and Saucier, Kirsten and Guemes-Aragon, Miriam and Kakar, Guntas and Rose, Madison and Pascal, Melanie and Alander, Cynthia and Mallya, Sanjay M and Arnold, Andrew},
title = {Influence of Vitamin D Deficiency on Cyclin D1-Induced Parathyroid Tumorigenesis},
journal = {Endocrinology},
year = {2023},
doi = {10.1210/endocr/bqad137}
}
EUVIMED